Free shipping on all orders over $ 500

Topiroxostat

Cat. No. M5203
Topiroxostat Structure
Synonym:

FYX-051

Size Price Availability Quantity
10mg USD 55  USD55 In stock
25mg USD 80  USD80 In stock
50mg USD 130  USD130 In stock
100mg USD 220  USD220 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Topiroxostat (FYX-051) is a novel and potent xanthine oxidoreductase (XOR) inhibitor with IC50 value of 5.3 nM. Topiroxostat (FYX-051) exhibited competitive-type inhibition with a Ki value of 5.7 × 10-9 M of native XO.

In vivo: In this hyperuricemic model, Topiroxostat in the dose range of 0.03 to 1 mg/kg caused a dose-dependent decrease in serum urate levels with an extremely low ED50 of 0.15 mg/kg, evaluated at 1 h after oral administration.

Chemical Information
Molecular Weight 248.24
Formula C13H8N6
CAS Number 577778-58-6
Form Solid
Solubility (25°C) DMSO 20 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Shimo T, et al. Arch Toxicol. Xanthine crystals induced by topiroxostat, a xanthine oxidoreductase inhibitor, in rats, cause transitional cell tumors.

[2] Matsumoto K, et al. J Pharmacol Exp Ther. FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase.

[3] Sato T, et al. Bioorg Med Chem Lett. Discovery of 3-(2-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected].

Related Xanthine Oxidase Products
H-Tyr-Phe-OH

H-Tyr-Phe-OH (L-Tyrosyl-L-phenylalanine) is an orally active inhibitor of Angiotensin converting enzyme (ACE), with an inhibiton rate of 48% at 50 μM.

TEI-6469

TEI-6469 is a xanthine oxidase (XO) inhibitor that may be used in studies related to gout.

Phytic acid dodecasodium hydrate

Phytic acid (Inositol hexaphosphate) dodecasodium hydrate is a phosphorus storage compound of seeds and cereal grains.

Ellagic acid-4-O-beta-D-xylopyranoside

Ellagic acid 4-O-β-D-xylopyranoside is a natural ellagitannin with antimicrobial activity. Ellagic acid 4-O-β-D-xylopyranoside is an xanthine oxidase inhibitor with an 50 of 2.1 μg/mL.

Protosappanin A dimethyl acetal

Protosappanin A dimethyl acetal is a homoisoflavonoid.

  Catalog
Abmole Inhibitor Catalog




Keywords: Topiroxostat, FYX-051 supplier, Xanthine Oxidase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.